Kewaunee Scientific CorporationKEQUNASDAQ
LOADING
|||
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -5.30% | +43.59% | +36.06% | +46.93% | +46.75% |
| Gross Profit Growth | +3.59% | +52.79% | +64.19% | +67.60% | +41.34% |
| EBITDA Growth | +0.04% | -13.25% | +325.61% | +75.60% | +17.67% |
| Operating Income Growth | -13.21% | -40.88% | +52.93% | +86.80% | -7.37% |
| Net Income Growth | +10.10% | -46.29% | -56.01% | +41.04% | -18.72% |
| EPS Growth | +11.70% | -45.98% | -55.96% | +40.26% | -19.05% |
| EPS Diluted Growth | +8.60% | -47.06% | -56.06% | +40.54% | -18.81% |
| Weighted Average Shares Growth | -1.07% | -0.73% | -0.14% | +0.07% | -0.45% |
| Weighted Average Shares Diluted Growth | +1.47% | +1.01% | +0.30% | -0.13% | +0.10% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +1029.32% | -123.85% | +721.57% | +0.00% | -150.56% |
| Free Cash Flow Growth | +0.00% | -132.74% | +5256.02% | +0.00% | -175.26% |
| Receivables Growth | -1.68% | +39.68% | +0.00% | +30.66% | +40.90% |
| Inventory Growth | -13.88% | +44.47% | +58.85% | +81.09% | +90.25% |
| Asset Growth | +10.49% | +49.75% | +44.44% | +46.56% | +40.60% |
| Book Value per Share Growth | +42.42% | +38.93% | +17.87% | +19.65% | +21.43% |
| Debt Growth | -43.55% | +40.75% | +28.16% | +65.14% | +115.03% |
| R&D Expense Growth | +0.00% | +0.00% | -0.11% | +0.00% | +0.00% |
| SG&A Expenses Growth | +23695.00% | +96.14% | +71.09% | -100.00% | -100.00% |